SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review

H Fathizadeh, S Afshar, MR Masoudi… - International Journal of …, 2021 - Elsevier
The world has been suffering from COVID-19 disease for more than a year, and it still has a
high mortality rate. In addition to the need to minimize transmission of the virus through non …

Review on up-to-date status of candidate vaccines for COVID-19 disease

TM Belete - Infection and drug resistance, 2021 - Taylor & Francis
The global pandemic of COVID-19 caused by SARS-CoV-2 continues to spread and poses
serious threats to public health and economic stability throughout the world. Thus, to protect …

Vaccine design and delivery approaches for COVID-19

K Shahzamani, F Mahmoudian… - International …, 2021 - Elsevier
COVID-19 is still a deadly disease that remains yet a major challenge for humans. In recent
times, many large pharmaceutical and non-pharmaceutical companies have invested a lot of …

A Review of the Progress and Challenges of Developing a Vaccine for COVID-19

O Sharma, AA Sultan, H Ding, CR Triggle - Frontiers in immunology, 2020 - frontiersin.org
A novel coronavirus, which has been designated as severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), was first detected in December 2019 in Wuhan China and …

COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies

K Rawat, P Kumari, L Saha - European journal of pharmacology, 2021 - Elsevier
Coronavirus Disease 2019 named as COVID-19 imposing a huge burden on public health
as well as global economies, is caused by a new strain of betacoronavirus named as SARS …

[HTML][HTML] COVID-19 vaccine: critical questions with complicated answers

MF Haidere, ZA Ratan, S Nowroz… - Biomolecules & …, 2021 - ncbi.nlm.nih.gov
COVID-19 has caused extensive human casualties with significant economic impacts
around the globe, and has imposed new challenges on health systems worldwide. Over the …

A focused review on technologies, mechanisms, safety, and efficacy of available COVID-19 vaccines

P Ghasemiyeh, S Mohammadi-Samani… - International …, 2021 - Elsevier
20 months has been passed since the detection of the first cases of SARS-CoV-2 infection
named COVID-19 from Wuhan city of China. This novel coronavirus spread rapidly around …

SARS-CoV-2 vaccines, vaccine development technologies, and significant efforts in vaccine development during the pandemic: the lessons learned might help to fight …

C Chakraborty, M Bhattacharya, K Dhama - Vaccines, 2023 - mdpi.com
We are currently approaching three years since the beginning of the coronavirus disease
2019 (COVID-19) pandemic. SARS-CoV-2 has caused extensive disruptions in everyday …

[HTML][HTML] Targets and strategies for vaccine development against SARS-CoV-2

JA Malik, AH Mulla, T Farooqi, FH Pottoo… - Biomedicine & …, 2021 - Elsevier
Abstract The SARS-CoV-2, previously called a novel coronavirus, that broke out in the
Wuhan city of China caused a significant number of morbidity and mortality in the world. It is …

[HTML][HTML] A review on the advancements in the development of vaccines to combat coronavirus disease 2019

H Onyeaka, ZT Al-Sharify, MY Ghadhban… - Clinical and …, 2021 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19), the deadly disease caused by SARS-CoV-
2 (severe acute respiratory syndrome coronavirus 2) is a global pandemic that has severely …